is saxenda a glp 1 agonist First Generic GLP-1 Injection OK'd for Weight Loss GLP-1 Receptor Agonists: Mascots &

Post hoc evaluations of the SUSTAIN 6 trial revealed that semaglutide markedly increased the incidence of diabetic retinopathy complications in individuals with a history of retinopathy, especially among insulin users, presumably due to the swift deterioration of pre-existing retinopathy following rapid glycemic control [91]

May 2022

Orforglipron Name: Orforglipron Manufacturer: Eli Lilly Current stage: Expected to submit for regulatory approval by the end of 2025 Takeaway: Less effective than injectables for mean weight loss, but a daily pill could suit some patients better

Is there any way you can naturally support your body's production of GLP-1